Key facts
- This page summarizes Shailesh Jejurikar's Form 4 filing for PROCTER & GAMBLE Co (PG).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 07 Aug 2025, 15:33.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Award
Award
Additional SEC filing notes
Footnote F1
Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSUs) settled in stock. The total includes an adjustment in the amount of 57.735 to correct an immaterial error in the number of RSUs due to dividend equivalents that were previously reported twice.
Footnote F2
Reflects adjustment to PST through July 14, 2025.
Footnote F3
Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
Footnote F4
These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
Footnote F5
Total includes an adjustment in the amount of 26.0366 to correct an immaterial error in the number of RSUs due to dividend equivalents that were previously reported twice.
Footnote F6
Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
Footnote F7
Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
Footnote F8
Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.